[CH2:1]([C@@H:9]1[NH:14][C:13](=O)[CH2:12][NH:11][C:10]1=O)[CH2:2][C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][CH:4]=1.[H-].[Al+3].[Li+].[H-].[H-].[H-].O.O.O.O.O.O.O.O.O.O.S([O-])([O-])(=O)=O.[Na+].[Na+].[H][H]>C1COCC1>[CH2:1]([C@H:9]1[CH2:10][NH:11][CH2:12][CH2:13][NH:14]1)[CH2:2][C:3]1[CH:4]=[CH:5][CH:6]=[CH:7][CH:8]=1Add 3-(S)-phenethyl-piperazine-2,5-dione (2.5 g, 11 mmol) portionwise to lithium aluminum hydride (1.75 g, 46 mmol) in THF (46 mL). Reflux the resulting suspension for an hour and cool to 0° C. Add sodium sulfate decahydrate carefully until hydrogen evolution ceases and stir the mixture for an additional three hours at room temperature and filter. Wash the solids with THF several times. Combine the filtrates, concentrate, and recrystallize the residue with THF/pentane to afford 2-(S)-phenethyl-piperazine as white crystals (1.9 g, 90%): mp 114–115° C.; 1H NMR (CDCl3): δ1.58–1,70 (m, 2H), 2.41 (dd, 1H), 2.58–3.02 (m, 8H), 7.16–7.30 (m, 5H); MS (APCI) m/z (rel intensity) 191 (100).